Aspirin for peripheral arterial disease
Examples
| aspirin |
Anacin,
Ascriptin [aspirin and an antacid],
Bayer,
Bufferin [coated to minimize stomach upset],
|
Brand-name aspirin is no more effective than generic or store
brands.
How It Works
Aspirin helps prevent the formation of
blood clots. This can decrease the chance that a blood clot will form and block
an already-narrowed artery.
Why It Is Used
Aspirin may be given to people who
have
peripheral arterial disease
(PAD) or risk factors for
peripheral arterial disease. It may also be used after bypass surgery or
angioplasty
to prevent the formation of blood clots
after these procedures.
How Well It Works
Research results vary on the
effects of aspirin for PAD, but it likely reduces the risk for
heart attack
and
stroke
.
1
Side Effects
Side effects of aspirin include:
- Inflammation of the stomach
(gastritis).
- Gastrointestinal bleeding.
- An allergic
reaction.
- In rare cases, bruising and bleeding (hemorrhage) in the
brain or other internal organs of the body.
See Drug Reference for a full list of side effects. (Drug
Reference is not available in all systems.)
What To Think About
Aspirin may be combined with
other antiplatelet or anticoagulant medicines.
Some doctors are
concerned that long-term daily aspirin use can increase the risk of stomach
problems. A smaller dose, such as a single low-dose aspirin, is often used and
appears to be just as effective as a higher dose. Consult your doctor before you start taking aspirin on a regular basis.
Because of aspirin's effect on blood clotting, your doctor may want you
to stop your aspirin at least 5 to 10 days before surgery and before any dental
procedure that may cause excessive bleeding.
Aspirin may also
lower the risk of heart attack and stroke, which are common causes of death in
people who have PAD.
Complete the
new medication information form (PDF)
(What is a
PDF
document?)
to help you understand this medication.
References
Citations
-
Regensteiner JG, Hiatt WR (2002). Current medical
therapies for patients with peripheral arterial disease: A critical review.
American Journal of Medicine, 112(1): 49–57.
Last Updated:October 30, 2007
Regensteiner JG, Hiatt WR (2002). Current medical
therapies for patients with peripheral arterial disease: A critical review.
American Journal of Medicine, 112(1): 49–57.